Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basmisanil in adults with severe motor impairment following ischemic stroke
2015-003227-66Phase 2Terminated
- Sponsor
- Roche
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke and stroke comparing Basmisanil with Placebo (2 arms). Primary endpoint: Change from baseline in FMMS at Day 90. Started Aug 2016; status: terminated.
02
Drugs
basmisanil
03
Conditions
ischemic strokestroke
Beyond the preview
Go deeper on 2015-003227-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003227-66.